BNC Wealth Management’s Pfizer PFE Stock Holding History

BNC Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,281	Closed	-$308K	–	106
2023 Q3	$308K	Sell	9,281 -223	-2%	-$7.89K	0.17%	77
2023 Q2	$349K	Sell	9,504 -1,415	-13%	-$55.1K	0.19%	73
2023 Q1	$445K	Buy	10,919 +20	+0.2%	+$864	0.25%	71
2022 Q4	$558K	Sell	10,899 -151	-1%	-$7.24K	0.33%	66
2022 Q3	$484K	Buy	11,050 +112	+1%	+$5.44K	0.29%	69
2022 Q2	$573K	Buy	10,938 +481	+5%	+$24.5K	0.3%	73
2022 Q1	$541K	Buy	10,457 +132	+1%	+$6.85K	0.27%	64
2021 Q4	$610K	Buy	10,325 +2,104	+26%	+$104K	0.29%	63
2021 Q3	$354K	Buy	8,221 +4	+0%	+$177	0.21%	65
2021 Q2	$322K	Sell	8,217 -720	-8%	-$28K	0.2%	67
2021 Q1	$324K	Sell	8,937 -1,875	-17%	-$66.6K	0.23%	59
2020 Q4	$398K	Buy	10,812 +2,276	+27%	+$83.5K	0.25%	72
2020 Q3	$297K	Buy	+8,536	New	+$299K	0.21%	69

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BNC Wealth Management's PFE Position: Q4 2023 in Review

BNC Wealth Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 9,281 shares — an estimated $308K sold.

BNC Wealth Management first reported a position in PFE in Q3 2020 and held it in 13 quarters. The position peaked at $610K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

BNC Wealth Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
BNC Wealth Management sold 9,281 Pfizer shares in Q4 2023, an estimated $308K.
BNC Wealth Management first reported a position in Pfizer in Q3 2020 and held it in 13 quarters.
BNC Wealth Management's Pfizer position peaked at $610K in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on BNC Wealth Management's 13F filing for Q4 2023, filed 9 Jan 2024.